NEW YORK – Lifebit said Tuesday that it partnered with Troper Wojcicki Philanthropies (TWP) to support the organization's Lung Cancer Genetics Study, a collaboration between 23andMe and more than 20 lung cancer advocacy groups.
Through this partnership, Lifebit will work with TWP on a platform to securely store and manage de-identified participant health and biomedical data. Beginning this summer, nonprofit researchers and institutions may begin submitting research proposals to gain access to these data at no cost through Lifebit's federated Trusted Research Environment.
Launched last year, the study aims to recruit up to 10,000 adults who have been diagnosed with any type of lung cancer at any stage to better understand the disease's underlying genetics and to improve detection, risk reduction, and patient care. Over 1,500 participants have been enrolled to date.
"We're thrilled to join forces with Troper Wojcicki Philanthropies in the fight against lung cancer," Lifebit CEO Maria Dunford said in a statement. "This partnership showcases the power of federated data solutions to accelerate research and uncover actionable insights, ultimately transforming patient outcomes."
Earlier this year, Lifebit also partnered with Psifas to develop a secure platform for clinico-genomics research in Israel.